Breaking
πŸ‡ΊπŸ‡Έ FDA
High impact News πŸ‡ΊπŸ‡Έ FDA
Bd TeamsInvestorsAnalysts

Munck Wilson Mandala Expands to Fort Worth, Taps Life Sciences Leader

Dallas-based Munck Wilson Mandala, LLP has launched a new office in Fort Worth, Texas, appointing veteran life sciences legal and business leader Quintin Cassady to head the expansion. This move underscores the firm's commitment to strengthening its presence in the rapidly growing North Texas life sciences corridor.

Executive Summary

  • Munck Wilson Mandala has opened its sixth Texas office in Fort Worth, extending the firm's regional footprint beyond its Dallas headquarters and existing locations in Austin, Houston, and Plano.
  • Partner Quintin Cassady, a former biotech general counsel, will lead the new office β€” bringing in-house perspective to the firm's life sciences practice.
  • The expansion signals a targeted bet on the Fort Worth region as an emerging node in the North Texas life sciences corridor, where biotech and healthcare companies are scaling operations.
  • Cassady's background in intellectual property, corporate transactions, and regulatory compliance positions the firm to serve companies navigating the complex pharmaceutical and biotech legal environment.

Market Impact

Regulatory high
Commercial high
Competitive medium
Investment high

Ask about this article

AI-assisted answers grounded in NovaPharmaNews intelligence

Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.

Munck Wilson Mandala Expands to Fort Worth, Taps Life Sciences Leader

Munck Wilson Mandala Expands to Fort Worth, Taps Life Sciences Leader

Dallas-based Munck Wilson Mandala, LLP has launched a new office in Fort Worth, Texas, appointing veteran life sciences legal and business leader Quintin Cassady to head the expansion. This move underscores the firm's commitment to strengthening its presence in the rapidly growing North Texas life sciences corridor. Dallas Innovates

Key Takeaways

  • Munck Wilson Mandala has opened its sixth Texas office in Fort Worth, extending the firm's regional footprint beyond its Dallas headquarters and existing locations in Austin, Houston, and Plano.
  • Partner Quintin Cassady, a former biotech general counsel, will lead the new office β€” bringing in-house perspective to the firm's life sciences practice.
  • The expansion signals a targeted bet on the Fort Worth region as an emerging node in the North Texas life sciences corridor, where biotech and healthcare companies are scaling operations.
  • Cassady's background in intellectual property, corporate transactions, and regulatory compliance positions the firm to serve companies navigating the complex pharmaceutical and biotech legal environment.

Munck Wilson Mandala Establishes Fort Worth Presence

Munck Wilson Mandala, LLP officially launched its Fort Worth office on June 2, 2026, marking the firm's sixth location across Texas. The expansion places partner Quintin Cassady at the helm, leveraging his deep expertise in the life sciences sector to drive client engagement in the region. Dallas Innovates

The firm, which already maintains offices in Dallas, Plano, Austin, and Houston, has been steadily building out its life sciences practice group. The Fort Worth launch represents a strategic decision to plant a flag in a market that has historically lived in Dallas's shadow but is increasingly attracting biotech and healthcare investment. Cassady's mandate is to build a client base among biotech, pharmaceutical, and healthcare companies operating in and around Tarrant County and the broader mid-cities region.

For business development teams and investors tracking the North Texas life sciences ecosystem, the move is a signal that established legal infrastructure is following the capital. Firms don't open offices in markets they expect to shrink.

Why Fort Worth Is Becoming a Life Sciences Hub

The Fort Worth region has been quietly building the ingredients for a life sciences cluster: proximity to the University of North Texas Health Science Center, growing venture interest in North Texas biotech, and a cost structure that undercuts coastal hubs. Munck Wilson Mandala's decision to open a dedicated office β€” rather than serving the market remotely from Dallas β€” reflects a conviction that local, specialized legal counsel is a competitive advantage for emerging life sciences companies that can't afford to fly in outside counsel for every patent filing or licensing negotiation. Dallas Innovates

The North Texas life sciences corridor, stretching from Dallas-Fort Worth down through Austin, has drawn increasing attention from investors and companies seeking alternatives to Boston and San Francisco. Fort Worth's lower operating costs, available lab space, and growing talent pipeline make it an attractive location for early- and mid-stage biotechs. A local office with a life sciences-focused partner lowers the friction for companies evaluating a move to the region.

What to watch: whether other specialized life sciences law firms and CROs follow Munck Wilson Mandala into Fort Worth. A clustering effect would validate the market's trajectory and accelerate deal flow in the region.

Quintin Cassady's In-House Perspective Sets the Firm Apart

Cassady's appointment is notable not just for his legal credentials but for his operational background. As a former general counsel for a biotech company, he has sat on the other side of the table β€” managing IP portfolios, structuring corporate transactions, and navigating regulatory compliance under the pressure of clinical timelines and board expectations. That experience is precisely what life sciences companies say they want from outside counsel: lawyers who understand the business, not just the statute. Dallas Innovates

His practice covers intellectual property strategy, patent prosecution, licensing deals, M&A support, and FDA regulatory matters β€” the core legal needs of any biotech or pharmaceutical company from seed stage through commercialization. For founders and C-suite leaders in the Fort Worth area, having a partner with Cassady's profile locally accessible could compress decision-making timelines on critical transactions.

The firm has also been adding scientific advisors and additional life sciences talent to its broader practice, suggesting the Fort Worth launch is part of a larger buildout rather than a one-off expansion. Dallas Innovates

Frequently Asked Questions

What is the significance of Munck Wilson Mandala's expansion into Fort Worth?

The expansion establishes Munck Wilson Mandala's sixth Texas office and strategically positions the firm to serve the growing life sciences sector in the Fort Worth area, led by a specialized life sciences attorney with in-house biotech experience.

Who is leading the new Fort Worth office and what is their expertise?

Quintin Cassady, a partner with extensive experience in life sciences legal and business matters β€” including prior roles as general counsel for a biotech company β€” is leading the Fort Worth office. His practice focuses on intellectual property, corporate transactions, and regulatory compliance.

What are the potential implications of this expansion for the life sciences industry?

This move provides enhanced legal infrastructure for life sciences companies in the Fort Worth region, potentially fostering further innovation and investment in the local biotech and healthcare ecosystem. It also signals to other service providers that Fort Worth is a market worth entering.

How does this expansion fit into Munck Wilson Mandala's broader growth strategy?

The Fort Worth office is part of a continued buildout of the firm's life sciences practice across Texas, which includes offices in Dallas, Plano, Austin, and Houston. The firm has been adding both legal and scientific advisory talent to support biotech and pharmaceutical clients at every stage of development.

Related coverage

This article follows our editorial standards. Report a correction via editorial contact.

Related Articles

Ten-Year-Old Cambridge Biotech Seeks Merger or Acquisition Amidst Market Pressures
Standard impact NewsJun 3, 2026

Ten-Year-Old Cambridge Biotech Seeks Merger or Acquisition Amidst Market Pressures

6 min

Dr. Sarah Mitchell
Biotech M&A Trends: Navigating the 2026 Outlook for Strategic Growth
Standard impact NewsJun 2, 2026

Biotech M&A Trends: Navigating the 2026 Outlook for Strategic Growth

9 min

Dr. Sarah Mitchell
Big Pharma's Shift to Smaller Deals Boosts Biotech Sector
Standard impact NewsJun 2, 2026

Big Pharma's Shift to Smaller Deals Boosts Biotech Sector

6 min

Dr. Sarah Mitchell